Skip to content

Battlefield Acupressure for Acute Back Pain Management in the Emergency Department

Battlefield Acupressure for Acute Back Pain Management in the Emergency Department: Evaluating Whether Auricular Acupressure Can Reduce Opiate Administration for Painful Conditions

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07771686
Acronym
ED
Enrollment
50
Registered
2026-08-18
Start date
2026-09-10
Completion date
2028-09-10
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Back Pain

Keywords

Acute Back Pain, Battlefield Acupressure, Auricular Acupressure

Brief summary

Patients frequently present to the emergency department for treatment of acute pain. In the emergency department, analgesic medications, particularly opiates, are most often the primary and only means of treatment. Alternative therapies such as traditional acupuncture have been studied and utilized in acute care settings; however, the need for extensive training, the use of needles, and state-specific acupuncture licensing requirements have been barriers to widespread use. Battlefield Auricular Acupressure (BAA) is a needle-free five-point technique on the outer ear that has been developed and employed by the military for a variety of painful conditions. The primary objective of this study is to determine if battlefield auricular acupressure (BAA), compared to a sham procedure, results in a reduction in pain score at 30 minutes and 60 minutes post-intervention, by at least 2 Numerical Rating Scale (NRS) points below their baseline pain score, compared to participants receiving a sham procedure, for adults who present to the emergency department with a chief complaint of back pain and/or low back.

Interventions

PROCEDUREBattlefield auricular acupressure

Battlefield auricular acupressure: Ear seeds will be applied to the five established BAA points: Cingulate Gyrus, Thalamus, Omega 2, Point Zero, and Shen Men.

PROCEDURESham

Ear seeds will be applied to five pre-defined, non-therapeutic points on the ear helix and lobe, chosen for their lack of known effect on pain. The procedure will be identical in duration and interaction to the BAA group.

Sponsors

Hackensack Meridian Health
Lead SponsorOTHER
New Jersey Health Foundation
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient (Age ≥ 18) presenting to the ED * Chief complaint of back pain and/or low back pain * Pain score ≥ 4 on 0-10 NRS

Exclusion criteria

* Pregnancy * Known allergy to adhesive * Presence of cochlear implants * Piercings at one or more of the BAA or sham sites * Having received analgesic medications within 4 hours of arrival to the ED or prior to intervention * Preferred language other than Spanish or English * Presence of a wound, sore, or active infection on the surface of the ear

Design outcomes

Primary

MeasureTime frameDescription
Change in Pain ScorePain scores will be assessed at baseline (prior to intervention), 30 (± 5) minutes post-intervention and 60 (± 10) minutes post-intervention.Pain scores will be measured using the Numeric Rating Scale (NRS) ranging from 0 ("no pain") to 10 ("worst pain imaginable")10. This study will compare the mean pain scores between the BAA group and the sham group.

Secondary

MeasureTime frameDescription
Incidence of Non-Opioid Analgesic Medication UseFrom intervention until ED disposition (on average 3.5 hours)The proportion of patients in each group who require at least one dose of a non-opioid analgesic.
Total Opioid Consumption in Morphine Milligram Equivalents (MME)From intervention until ED disposition (on average 3.5 hours)A continuous variable representing the sum of all opioid doses received, converted to a standardized value. MME is a universal conversion system that turns all opioids into a single, standard unit using the formula: MME = (Dose of the Opioid in mg) x (Its Conversion Factor).
Incidence of Opioid Medication UseFrom intervention until ED disposition (on average 3.5 hours)The proportion of patients in each group (intervention vs. sham) who are administered an opioid analgesic following the intervention. This is a specific subset of analgesia and will be analyzed as a dichotomous (yes/no) outcome.
Change in Pain Score at 24 Hours24 hours post interventionTo assess the lasting effect of the intervention, a delayed follow-up 24-hour assessment will be conducted. Pain scores will be measured using the Numeric Rating Scale (NRS) ranging from 0 ("no pain") to 10 ("worst pain imaginable")10. Delayed follow-up pain score will be calculated as (NRS at 24 hours) - (NRS at baseline).
Incidence of Any Analgesic Medication UseFrom intervention until ED disposition (on average 3.5 hours)The proportion of patients in each group (intervention vs. sham) who require any analgesic medication following the intervention. This will be analyzed as a dichotomous (yes/no) outcome.
Frequency of Non-Opioid Analgesic DosesFrom intervention until ED disposition (on average 3.5 hours)A continuous variable representing the total number of doses of non-opioid analgesics administered stratified by drug class (NSAIDs vs acetaminophen).

Countries

United States

Contacts

CONTACTDiana McCarthy, MSN, RN
Diana.McCarthy@hmhn.org551-996-3209
PRINCIPAL_INVESTIGATORBiren Bhatt, MD

Hackensack Meridian Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026